logo

VIYASH vs WOCKPHARMA: Stock Comparison

VIYASH SCIENTIFIC vs WOCKHARDTUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

WOCKHARDT is the larger company by market capitalisation. VIYASH SCIENTIFIC shows a lower P/E, a higher ROE and lower leverage, while WOCKHARDT shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

VIYASH leads 6; WOCKPHARMA leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

VIYASHWOCKPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹9,199 Cr
₹30,126 Cr
P/E RatioVIYASH has the lower reading
49.82x ✓
73.66x
P/B RatioVIYASH has the lower reading
3.12x ✓
6.1x
EPSWOCKPHARMA has the higher reading
₹1.51
₹6.52 ✓
Book ValueContext only
₹71.3
₹325
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹30,126 Cr vs ₹9,199 Cr
P/E Ratio
VIYASH has a lower P/E
49.82x vs 73.66x
P/B Ratio
VIYASH has a lower P/B
3.12x vs 6.1x
EPS
WOCKPHARMA has higher earnings per share
₹6.52 vs ₹1.51
Revenue Growth (TTM YoY)
WOCKPHARMA has faster revenue growth
26% vs 0%
ROE
VIYASH has a higher ROE
7.21% vs 3.77%
ROCE
VIYASH has a higher ROCE
8.17% vs 5.44%
Net Margin
VIYASH has a higher net margin
6.57% vs 3.3%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricVIYASHWOCKPHARMA
Sector—Healthcare
Industry—Pharmaceuticals

Price

MetricVIYASHWOCKPHARMA
Live Price₹207.99₹1,855.5
Day Change-2.62%-1.16%
Volume21.17 L4.57 L
52-Week High₹298₹2,422.3
52-Week Low₹178.13₹1,086.7
Distance from 52W High-30.2%-23.4%

Valuation

MetricVIYASHWOCKPHARMA
Market Cap₹9,199 Cr₹30,126 Cr
P/E Ratio49.82x73.66x
P/B Ratio3.12x6.1x
EPS₹1.51₹6.52
Book Value₹71.3₹325
Dividend Yield0%0%

Growth

MetricVIYASHWOCKPHARMA
Revenue Growth (TTM YoY)0%26%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricVIYASHWOCKPHARMA
ROE7.21%3.77%
ROCE8.17%5.44%
Net Margin6.57%3.3%
Operating Margin12.23%13.37%
Debt to Equity0.14x0.4x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricVIYASHWOCKPHARMA
Promoter Holding0%49.08%
FII Holding2.6%▼ 1.9 pp7.22%▲ 0.13 pp
DII Holding8.3%▲ 4.55 pp9.24%▼ 1.72 pp
Public Holding39.76%▲ 9.42 pp34.44%▲ 1.61 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: VIYASH SCIENTIFIC and WOCKHARDT.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.